 | Up a level |
Warschkow, Rene; Güller, Ulrich; Cerny, Thomas; Schmied, Bruno Martin; Plasswilm, Ludwig; Putora, Paul Martin (2017). Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiotherapy and oncology, 123(1), pp. 139-146. Elsevier 10.1016/j.radonc.2017.02.007
Vogt, Alexia; Schmid, Sabine; Heinimann, Karl; Frick, Harald; Herrmann, Christian; Cerny, Thomas; Omlin, Aurelius Gabriel (2017). Multiple primary tumours: challenges and approaches, a review. ESMO open, 2(2), e000172. BMJ 10.1136/esmoopen-2017-000172
Tarantino, Ignazio; Warschkow, Rene; Worni, Mathias; Cerny, Thomas; Ulrich, Alexis; Schmied, Bruno M; Güller, Ulrich (2015). Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis. Annals of surgery, 262(1), pp. 112-120. Lippincott Williams & Wilkins 10.1097/SLA.0000000000000860
Huwiler, Karin; Thürlimann, Beat; Cerny, Thomas; Zwahlen, Marcel (2015). Comment on: ‘Screening’ for Breast Cancer: Misguided Research Misinforming Public Policies, by O. S. Miettinen. Epidemiologic Methods, 4(1), pp. 15-8. De Gruyter 10.1515/em-2015-0022
Castleberry, A. W.; Güller, Ulrich; Tarantino, I.; Berry, M. F.; Brügger, Lukas; Warschkow, R.; Cerny, Thomas; Mantyh, C. R.; Candinas, Daniel; Worni, Mathias (2014). Discrete Improvement in Racial Disparity in Survival among Patients with Stage IV Colorectal Cancer: a 21-Year Population-Based Analysis. Journal of gastrointestinal surgery, 18(6), pp. 1194-1204. Springer 10.1007/s11605-014-2515-3
Tarantino, Ignazio; Achermann, Philipp; Güller, Ulrich; Ulrich, Alexis; Schmied, Bruno M; Horber, Daniel; Cerny, Thomas; Stanga, Zeno; Warschkow, Rene (2013). Relative survival is an adequate estimate of cancer-specific survival: baseline mortality-adjusted 10-year survival of 771 rectal cancer patients. Annals of surgical oncology, 20(12), pp. 3877-3884. Springer 10.1245/s10434-013-3173-5
Egger, Matthias; Zwahlen, Marcel; Cerny, Thomas (2013). Cancer screening - principles, evaluation and implementation. Therapeutische Umschau, 70(4), pp. 195-203. Bern: Huber 10.1024/0040-5930/a000390
Worni, Mathias; Güller, Ulrich; White, Rebekah R.; Castleberry, Anthony W.; Pietrobon, Ricardo; Cerny, Thomas; Gloor, Beat; Köberle, Dieter (2013). Modest Improvement in Overall Survival for Patients With Metastatic Pancreatic Cancer. Pancreas, 42(7), pp. 1157-1163. Lippincott Williams & Wilkins 10.1097/MPA.0b013e318291fbc5
Joerger, Markus; Ferreri, Andrés J M; Krähenbühl, Stephan; Schellens, Jan H M; Cerny, Thomas; Zucca, Emanuele; Huitema, Alwin D R (2012). Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate. British journal of clinical pharmacology, 73(2), pp. 240-7. Oxford: Wiley-Blackwell 10.1111/j.1365-2125.2011.04084.x
Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Utiger, Urs; Cerny, Thomas; Hess, Urs; Bassi, Simona; Okkinga, Emmie; Stupp, Roger; Stahel, Rolf; Heizmann, Marc; Vorobiof, Daniel; Lohri, Andreas; Dietrich, Pierre-Yves; Zucca, Emanuele; Ghielmini, Michele (2010). Long Term Follow-Up Of Patients With Follicular Lymphoma Receiving Single Agent Rituximab At Two Different Schedules In Trial SAKK 35/98. Journal of clinical oncology, 28(29), pp. 4480-4484. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.28.4786
Cerny, David; Cerny, Thomas; Ess, Silvia; D'Addario, Giannicola; Früh, Martin (2009). Lung cancer in the Canton of St. Gallen, Eastern Switzerland: sex-associated differences in smoking habits, disease presentation and survival. Onkologie, 32(10), pp. 569-573. Karger 10.1159/000232581
Strasser, Florian; Demmer, Ruth; Böhme, Christel; Hsu Schmitz, Shu-Fang; Thuerlimann, Beat; Cerny, Thomas; Gillessen, Silke (2008). Prevention of Docetaxel- or Paclitaxel-Associated Taste Alterations in Cancer Patients with Oral Glutamine: A Randomized, Placebo-Controlled, Double-Blind Study. Oncologist, 13(3), pp. 337-346. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2007-0217
Lanz, Christian; Früh, Martin; Thormann, Wolfgang; Cerny, Thomas; Lauterburg, Bernhard H (2007). Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC. Journal of separation science, 30(12), pp. 1811-20. Weinheim: Wiley-VCH 10.1002/jssc.200600534
Heusser, Peter; Braun, Sarah Berger; Bertschy, Manuel; Burkhard, René; Ziegler, Renatus; Helwig, Silke; van Wegberg, Brigitte; Cerny, Thomas (2006). Palliative in-patient cancer treatment in an anthroposophic hospital: II. Quality of life during and after stationary treatment, and subjective treatment benefits. Forschende Komplementärmedizin und klassische Naturheilkunde, 13(3), pp. 156-66. Basel: Karger 10.1159/000092448
Heusser, Peter; Braun, Sarah Berger; Ziegler, Renatus; Bertschy, Manuel; Helwig, Silke; van Wegberg, Brigitte; Cerny, Thomas (2006). Palliative in-patient cancer treatment in an anthroposophic hospital: I. Treatment patterns and compliance with anthroposophic medicine. Forschende Komplementärmedizin und klassische Naturheilkunde, 13(2), pp. 94-100. Basel: Karger 10.1159/000091694
Cerny, Thomas; Betticher, Daniel (2000). Non-Hodgkin's lymphoma: Role of high-dose therapy in diffuse large B-cell lymphoma. Annals of oncology, 11(suppl 3), pp. 117-121. Oxford University Press 10.1093/annonc/11.suppl_3.117
Pagani, O.; Sessa, C.; Martinelli, G.; Cerny, Thomas; De Jong, J.; Goldhirsch, A.; Zimatore, M.; Cavalli, F. (1997). Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer. Annals of oncology, 8(7), pp. 655-661. Oxford University Press 10.1023/A:1008211629858
Betticher, D. C.; Zucca, E.; Von Rohr, A.; Egger, T.; Radford, J. A.; Ambrosetti, A.; Bürki, K.; Rufener, B.; Hsu Schmitz, S. F.; Cerny, Thomas (1996). 2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma. Annals of oncology, 7(8), pp. 793-799. Oxford University Press 10.1093/oxfordjournals.annonc.a010757
Haine, Axel; Jungi, Silvan; Banz, Yara (2019). Gefässe. In: Cerny, Thomas; Karlin, Kirill (eds.) PathoMaps: klinisch-pathologische Übersichtskarten (pp. 15-19). Springer Verlag 10.1007/978-3-662-57439-3_3
Trepp, Roman; Hewer, Ekkehard; Perren, Aurel (2019). Hypophyse und Nebenniere. In: Cerny, Thomas; Karlin, Kirill (eds.) PathoMaps. Springer-Lehrbuch (pp. 137-141). Springer 10.1007/978-3-662-57439-3_20
Trepp, Roman; Perren, Aurel (2019). Schilddrüse und Nebenschilddrüse. In: Cerny, Thomas; Karlin, Kirill (eds.) PathoMaps. Springer-Lehrbuch (pp. 143-147). Springer-Verlag 10.1007/978-3-662-57439-3_21
Heinimann, Karl; Perren, Aurel (2019). Erbliche Tumorerkrankungen und Phakomatosen. In: Cerny, Thomas; Karlin, Kirill (eds.) PathoMaps. Springer-Lehrbuch (pp. 177-181). Springer-Verlag 10.1007/978-3-662-57439-3_25
Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Martinelli, Giovanni; Peccatori, F; Hess, Urs; Fey, Martin; Zucca, Emanuele; Stahel, Rolf; Ketterer, Nicolas; Cerny, Thomas (2009). Long-term follow-up of patients with follicular lymphoma (FL) receiving single agent rituximab at two different schedules in study SAKK 35/98. Journal of clinical oncology, 27(15), p. 8512. American Society of Clinical Oncology
